COMPASS Pathways plc (CMPS)
Dopo ore:
| Chiusura precedente | 10,72 |
| Aperto | 10,83 |
| Denaro | 10,45 x 1000 |
| Lettera | 10,98 x 1100 |
| Min-Max giorno | 10,64 - 10,92 |
| Intervallo di 52 settimane | 6,54 - 21,50 |
| Volume | |
| Media Volume | 283.296 |
| Capitalizzazione | 455,569M |
| Beta (5 anni mensile) | 2,29 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,94 |
| Prossima data utili | 03 nov 2022 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 44,64 |
- GlobeNewswire
COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP
12 out of 14 patients went into remission for three months following a single 25mg dose of COMP360 psilocybin therapy, in an independent investigator-initiated, exploratory open-label study of type II bipolar disorder New data from COMPASS’ phase 2b trial, also presented at ACNP, validate potential of COMP360 psilocybin therapy in treatment-resistant depression LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to acc
- GlobeNewswire
COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference
LONDON, Nov. 28, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Evercore ISI HealthCONx Conference at 9:15am ET on 30 November 2022. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the COMPASS website. The replay of the webcast will be acc
- GlobeNewswire
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
LONDON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Highlights: Phase 3 pivotal program design finalized and on track to start in 2022; several clinical sites have been initiatedPhase 2b trial data published in The New England Journal of MedicineCash position at 30 September 2022 of $173.1 millionConference call today at 8:00am ET (12:00pm UK) COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health
